---
title: Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer
nct_id: NCT05842031
overall_status: SUSPENDED
sponsor: M.D. Anderson Cancer Center
study_type: OBSERVATIONAL
primary_condition: Penile Cancer
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT05842031.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT05842031"
ct_last_update_post_date: 2026-03-04
last_seen_at: "2026-05-12T07:10:28.485Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer

**NCT ID:** [NCT05842031](https://clinicaltrials.gov/study/NCT05842031)

## Key Facts

- **Status:** SUSPENDED
- **Why Stopped:** PI requested
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 20
- **Lead Sponsor:** M.D. Anderson Cancer Center
- **Conditions:** Penile Cancer
- **Start Date:** 2023-04-14
- **Completion Date:** 2026-12-31
- **CT.gov Last Update:** 2026-03-04

## Brief Summary

To learn more about the patient experience undergoing inguinal (in the groin) lymph node procedures for penile cancer during and after surgery.

## Detailed Description

Objectives

Primary Objective:

To understand the lived experience of patients undergoing invasive inguinal lymph node procedures.

Secondary Objective:

To determine factors that influence decisions and improve experience for patients who need invasive inguinal lymph node procedures.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** MALE
- **Healthy Volunteers:** No

```
Inclusion Criteria:

--Patients diagnosed with penile cancer who have undergone invasive inguinal node procedures (ILND and/or DSNB) and are at least 6 months post-procedure

Exclusion Criteria:

* Patient's ≤18 years of age
* Patients who have not undergone invasive surgical procedures involving the inguinal lymph nodes
* Non-English-speaking patients For interviews: people who are physically and/or cognitively incapable of participating in a 60minute telephone interview as determined by a clinical provider or the patient.
```

## Arms

- **Semi-structured interviews** — Participants with penile cancer who have undergone invasive inguinal lymph node procedure will be recruited to participate in study via telephone recruitment.

## Interventions

- **Quality of Life Questionnaires** (BEHAVIORAL) — Identify what interventions may be helpful in improving quality of life.
- **Patient Educational Needs** (BEHAVIORAL) — Identify what interventions may be helpful in improving patient educational needs
- **Symptom Management** (BEHAVIORAL) — Identify what interventions may be helpful in improving symptom management Improve symptom management

## Primary Outcomes

- **Decision Regret Scale (DRS) questionnaires** _(time frame: through study completion; an average of 1 year)_ — Score Scale ranges (1-5)

1. Strongly Agree
2. Agree
3. Agree nor Disagree
4. Disagree
5. Strongly Disagree

## Locations (1)

- MD Anderson, Houston, Texas, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.whyStopped` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.md anderson|houston|texas|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT05842031.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT05842031*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*